D-0344-2026 Class II Ongoing

Recalled by Agebox — Wilmington, DE

FDA drug recall D-0344-2026 was initiated by Agebox on Oct 28, 2025 and is designated Class II. Reason for recall: Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren The recall status is ongoing. Affected quantity: 665 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 4, 2026
Initiation Date
Oct 28, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
665 bottles

Product description

Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 8 50065 59701 0

Reason for recall

Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Distribution pattern

The product was distributed nationwide in the U.S. Agebox sells its U.S. products through Agebox.com (using Shopify) and Amazon.com. All orders are shipped to customers by Agebox itself; other parties are not involved in the distribution of the physical product.

Code information

Lot # 23101201 exp 09/2026, 24080801 exp 07/2027, and 25020701 exp 01/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0344-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0344-2026. Report a data issue: hello@regdatalab.com.